New blood test pinpoints Parkinson’s disease through mitochondrial DNA damage

Researchers have developed a new blood test that measures mitochondrial DNA damage as a potential marker for Parkinson’s disease (PD). The study shows the test could aid in diagnosing PD and assessing responses to LRRK2 kinase inhibitors, which may help in reducing mitochondrial damage in PD patients.

PAION AG announces fully underwritten rights issue with target gross proceeds of EUR 10 million – Biotech Investments

PAION AG / Key word(s): Capital Increase PAION AG announces fully underwritten rights issue with target gross proceeds of EUR 10 million 13-Oct-2023 / 12:57

October 14, 2023

Statin Reduced Risk of Heart Disease in People With HIV

BRISBANE, Australia — The cholesterol-lowering agent pitavastatin (Livalo) as primary prevention reduced the risk of major adverse cardiovascular events (MACE) among people living with HIV,

July 25, 2023

Aging Fly Cell Atlas Reveals Patterns of Gene Expression in Different Cell Types

As the body ages, organ function progressively declines and the risk for a wide range of diseases, including cardiovascular disease, cancer, and neurodegenerative diseases increases.

June 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.